Rady Children's Institute for Genomic Medicine
Daniel Perry is a seasoned business systems analyst currently employed at Rady Children's Institute for Genomic Medicine since January 2020. Prior to this role, Daniel served as an applications analyst II at Mass General Brigham from February 2014 to January 2020, where responsibilities included project management, system enhancements, and cross-functional collaboration to meet technical and business needs. Earlier experience at State Street from October 2007 to February 2014 encompassed roles as a business analyst and investment services accounting specialist, focusing on operational efficiencies and accounting processes. Daniel holds a Bachelor of Arts in Philosophy from the University of Massachusetts Amherst and has a background from Xaverian Brothers High School.
Rady Children's Institute for Genomic Medicine
The Rady Children's Institute for Genomic Medicine is leading the way in advancing precision healthcare for infants and children through genomic and systems medicine research. Discoveries at the Institute are enabling rapid diagnosis and targeted treatment of critically ill newborns and pediatric patients at Rady Children’s Hospital-San Diego. The vision is to expand delivery of this integrated translational research process to enable the practice of precision pediatric medicine at children’s hospitals across California, the nation and the world. RCIGM is a subsidiary of Rady Children’s Hospital and Health Center. Learn more at www.RadyGenomics.org.